# Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

> **NCT00795457** · EARLY_PHASE1 · COMPLETED · sponsor: **Ian F. Pollack, M.D.** · enrollment: 13 (actual)

## Conditions studied

- Astrocytoma
- Oligo-Astrocytoma
- Glioma

## Interventions

- **BIOLOGICAL:** GAA/TT-peptide vaccine and poly-ICLC
- **BIOLOGICAL:** GAA/TT-peptide vaccine and poly-ICLC

## Key facts

- **NCT ID:** NCT00795457
- **Lead sponsor:** Ian F. Pollack, M.D.
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-02
- **Final completion:** 2015-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2019-08-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795457, "Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00795457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*